Long-term safety and efficacy of CART-20 cells in patients with refractory or relapsed B-cell non-Hodgkin lymphoma: 5-years follow-up results of the phase I and IIa trials

Detalles Bibliográficos
Autores principales: Zhang, Wen-ying, Liu, Yang, Wang, Yao, Wang, Chun-meng, Yang, Qing-ming, Zhu, Hong-li, Han, Wei-dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5661643/
https://www.ncbi.nlm.nih.gov/pubmed/29263931
http://dx.doi.org/10.1038/sigtrans.2017.54
Descripción
Sumario:

Ejemplares similares